Accelerating Clinical Development of Next-Gen Therapies Outside of the US

Create Targeted & Scalable Cell Therapies through In-Vivo Innovation, Automated Manufacturing, & Strategic Partnerships that Secure Future Cash Flow in Europe

Cell therapy is at a pivotal moment, with global investment and innovation reshaping the landscape. While funding challenges persist, Europe and Asia are emerging as hotspots for rapid clinical development and strategic partnerships. The rise of in-vivo CAR-T and next-generation TCR approaches highlights a shift toward scalable, cost-effective therapies that could transform patient access and commercial feasibility.

Returning to London for its 9th year, the CAR-TCR Summit Europe is the essential forum to gain cutting-edge scientific insights, practical manufacturing strategies, and business intelligence to accelerate clinical success. Attendees will explore advances in novel CAR and TCR designs, armouring, and engineered signalling pathways, while also learning how leading institutions are improving scale, automation, and point-of-care solutions to reduce costs and enhance reliability.

Connect with Europe’s leading companies and research centres to stay ahead in innovation, strengthen manufacturing capabilities, and build the partnerships needed to drive the next generation of life-saving cell therapies across the continent and beyond.

Download the Agenda

Very focused on the topic at hand, highly relevant presentations. It was my first CAR-T/TCR-T conference and I got what I was looking for - information AND opinions of the community.

Chief Business Officer, Captain T-Cell, 2025 Attendee

It was an incredible opportunity to hear from the world's leading developers of novel cell therapies. What stood out to me was the extremely insightful presentations and discussion panels.

Business Development Manager, Nona Biosciences, 2025 Attendee

The CAR-TCR Summit is truly unique in its depth and breadth. It brings together every aspect of the field, from basic discovery to clinical application and commercialisation. What makes it exceptional is the combination of top-tier scientists, industry leaders, and key decision-makers in one forum. It’s an invaluable opportunity to exchange insights, align standards, and collectively shape the future of cell therapy innovation.

Group Leader, Heidelberg University Hospital, 2026 Speaker